文献速递造血干细胞移植与细胞治疗白血病

AML单倍体移植后aGVHD危险因素分析

[Identifying risk factors for acute graft-versus-host disease in patients with acute myeloid leukemia undergoing haploidentical hematopoietic stem cell transplantation].
PubMed 文献 · Zhonghua Xue Ye Xue Za Zhi · 2025-01-01

本研究纳入141例接受单倍体造血干细胞移植的急性髓系白血病患者,采用Fine-Gray竞争风险模型和Cox回归分析aGVHD的危险因素。多因素分析确认供者年龄和女供男性别组合是aGVHD的独立危险因素,供者>45岁及女供男组合的患者100天Ⅱ~Ⅳ度aGVHD累积发生率显著更高。

要点

  • 供者年龄是aGVHD独立危险因素,多因素HR=1.026(95%CI 1.008-1.047,P=0.005)。
  • 女供男性别组合是aGVHD独立危险因素,多因素HR=2.339(95%CI 1.354-4.037,P=0.002)。
  • 供者>45岁者100天Ⅱ~Ⅳ度aGVHD累积发生率54.7%,显著高于≤45岁者的31.6%(P=0.006)。

核心结论

  • 年长供者和女性供者对男性受者是AML患者接受HID-HSCT后发生aGVHD的独立危险因素。

研究设计与样本

  • 回顾性纳入2020年1月至2021年7月在中国医学科学院血液病医院接受HID-HSCT的141例AML患者,男86例(61.0%),女55例(39.0%),中位移植年龄34岁。
  • 采用Fine-Gray竞争风险模型分析aGVHD累积发生率,以复发和死亡为竞争事件,并用Cox比例风险回归进行单因素及多因素分析。

主要发现

  • 141例中59例在移植后100天内发生Ⅱ~Ⅳ度aGVHD,86例为0~Ⅰ度aGVHD。
  • Ⅱ~Ⅳ度aGVHD组3年总生存率68.7%(95%CI 57.7%-81.9%),0~Ⅰ度组78.8%(95%CI 70.4%-88.3%),差异无统计学意义(P=0.190)。
  • 单因素分析显示供者年龄(P=0.020,HR=1.020,95%CI 1.000-1.040)和女供男性别组合(P=0.033,HR=1.980,95%CI 1.160-3.380)是Ⅱ~Ⅳ度aGVHD危险因素。
  • 多因素分析确认供者年龄(P=0.005,HR=1.026,95%CI 1.008-1.047)和女供男性别组合(P=0.002,HR=2.339,95%CI 1.354-4.037)为独立危险因素。

关键数值与推荐

  • 供者>45岁者100天Ⅱ~Ⅳ度aGVHD累积发生率54.7%(95%CI 42.3%-67.0%),供者≤45岁者31.6%(95%CI 21.0%-42.1%),P=0.006。
  • 女供男性别组合者100天Ⅱ~Ⅳ度aGVHD累积发生率56.8%(95%CI 40.4%-73.1%),其他性别组合者36.9%(95%CI 27.5%-46.3%),P=0.015。

临床怎么用

  • 对于接受HID-HSCT的AML患者,选择供者时应考虑供者年龄及供受者性别组合,供者>45岁或女供男组合提示aGVHD风险较高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To identify the risk factors for acute graft-versus-host disease (aGVHD) in patients with acute myeloid leukemia (AML) undergoing haploidentical hematopoietic stem cell transplantation (HID-HSCT) . Methods: A total of 141 AML patients who underwent HID-HSCT at the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, from January 2020 to July 2021 were included. The cumulative incidence of aGVHD was analyzed using the Fine-Gray competing risk model, with relapse and death as competing events, to compare differences between groups. Potential risk factors were evaluated by univariable and multivariable Cox proportional hazards regression analyses to determine their independent effects on aGVHD. Results: Among the 141 patients, 86 (61.0%) were male and 55 (39.0%) were female, with a median age at transplantation of 34 years. Within 100 days post-transplant, 59 patients developed grade Ⅱ-Ⅳ aGVHD, whereas 86 patients experienced no or grade Ⅰ aGVHD (the grade 0-Ⅰ aGVHD group) . Survival analysis showed that the 3-year overall survival was 68.7% (95% CI: 57.7%-81.9%) in the grade Ⅱ-Ⅳ aGVHD group, compared with 78.8% (95% CI: 70.4%-88.3%) in the grade 0 - Ⅰ aGVHD group, with the difference not being statistically significant (P=0.190) . Univariable analysis identified donor age (P=0.020, HR=1.020, 95% CI: 1.000-1.040) and the female donor-male recipient sex combination (P=0.033, HR=1.980, 95% CI: 1.160-3.380) as risk factors for grade Ⅱ-Ⅳ aGVHD. Multivariable analysis confirmed that donor age (P=0.005, HR=1.026, 95% CI: 1.008-1.047) and the female donor-male recipient sex combination (P=0.002, HR=2.339, 95% CI: 1.354-4.037) were independent risk factors for aGVHD. Patients receiving grafts from donors aged >45 years had a significantly higher 100-day cumulative incidence of grade Ⅱ-Ⅳ aGVHD compared with those receiving grafts from donors ≤45 years [54.7% (95% CI: 42.3%-67.0%) vs 31.6% (95% CI: 21.0%-42.1%) , P=0.006]. Similarly, patients with the female donor-male recipient sex combination had a higher 100-day cumulative incidence of grade Ⅱ-Ⅳ aGVHD than those with other sex combinations [56.8% (95% CI: 40.4%-73.1%) vs 36.9% (95% CI: 27.5%-46.3%) , P=0.015]. Conclusion: Older donor age and the female donor-male recipient sex combination remain independent risk factors for aGVHD in patients with AML undergoing HID-HSCT. 目的: 明确接受单倍体/半相合造血干细胞移植(HID-HSCT)的急性髓系白血病(AML)患者发生急性移植物抗宿主病(aGVHD)的危险因素。 方法: 纳入2020年1月至2021年7月于中国医学科学院血液病医院接受HID-HSCT治疗的141例AML患者,aGVHD的累积发生率采用Fine-Gray竞争风险模型进行分析,以复发和死亡作为竞争风险事件,比较不同组之间aGVHD的累积发生率差异。采用Cox比例风险回归模型对潜在危险因素进行单因素及多因素分析,以评估其对aGVHD发生风险的独立影响。 结果: 141例患者中男86例(61.0%),女55例(39.0%),患者接受移植的中位年龄为34岁。59例患者在移植后100 d内发生Ⅱ~Ⅳ度aGVHD,86例未发生aGVHD或表现为Ⅰ度aGVHD(0~Ⅰ度aGVHD组)。生存分析显示,Ⅱ~Ⅳ度aGVHD组患者的3年总生存率为68.7%(95%CI:57.7%~81.9%),与0~Ⅰ度aGVHD组的78.8%(95%CI:70.4%~88.3%)比较差异无统计学意义(P=0.190)。单因素分析显示供者年龄(P=0.020,HR=1.020,95%CI: 1.000~1.040)以及女供男性别组合(P=0.033,HR=1.980,95% CI: 1.160~3.380)是Ⅱ~Ⅳ度aGVHD发生的危险因素。多因素分析表明供者年龄(P=0.005,HR=1.026,95% CI: 1.008~1.047)、女供男性别组合(P=0.002,HR=2.339,95% CI: 1.354~4.037)是aGVHD发生的独立危险因素。接受>45岁供者移植的患者在移植后100 d内的Ⅱ~Ⅳ度aGVHD累积发生率显著高于供者年龄≤45岁的患者[54.7%(95%CI: 42.3%~67.0%)对31.6%(95%CI: 21.0%~42.1%),P=0.006]。女供男性别组合的患者在移植后100 d内的Ⅱ~Ⅳ度aGVHD累积发生率显著高于其他性别组合[56.8%(95%CI: 40.4%~73.1%)对36.9%(95%CI: 27.5%~46.3%),P=0.015]。 结论: 年长供者、女性供者对男性受者是AML患者接受HID-HSCT后发生aGVHD的独立危险因素。.

来源:Zhonghua Xue Ye Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Feng D, Liang W, Cao JX, et al. [Identifying risk factors for acute graft-versus-host disease in patients with acute myeloid leukemia undergoing haploidentical hematopoietic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi. 2025. PMID: 41339044. doi:10.3760/cma.j.cn121090-20250114-00027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。